Trump's FDA nominee tepidly backs role for vaccine advisers in guarded Senate appearance
Martin Makary, President Donald Trump's nominee to run the U.S. FDA, told lawmakers on Thursday he would convene a committee of vaccine advisers but said he would reevaluate which scientific issues require their input.
3don MSN
President Donald Trump’s pick to lead the US Food and Drug Administration told senators in a tense confirmation hearing ...
An FDA vaccine advisory committee meeting to discuss next season’s flu vaccine has been canceled, potentially delaying the ...
Five years after the start of the pandemic, the fight over who owns the underlying technologies that made the Covid-19 ...
The Food and Drug Administration (FDA) abruptly canceled a vaccine advisory meeting where members were slated to discuss ...
If confirmed, Makary would run one of the nation's leading health agencies, overseeing the regulation of food and drugs.
Dr. Marty Makary is largely sidestepping Senate questions about his plans to lead the Food and Drug Administration ...
Scientist Stephen Krahling worked on a project at Merck called “Protocol 7” and was uniquely positioned to blow the whistle on what he learned.
A March meeting of outside advisers to the US Food and Drug Administration to discuss the composition of flu vaccines for ...
The Florida surgeon general in January called for a halt in the use of covid mRNA vaccines. And in Texas, Attorney General ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback